Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hande, Kocar"'
Publikováno v:
Journal of Oncological Sciences, Vol 2, Iss 1, Pp 12-15 (2016)
Aim: This study retrospectively assessed the efficacy and tolerability of combination chemotherapy with cisplatin, infusional 5-fluorouracil and folinic acid given every two weeks and subsequent chemoradiotherapy with continuous infusions of 5-fluoro
Externí odkaz:
https://doaj.org/article/02e17e571daf4be69cb2ffac3b53987a
Autor:
Muharrem, Kocar, Emine, Bozkurtlar, Ferhat, Telli, Nazim, Serdar Turhal, Handan, Kaya, Hande, Kocar, Fulden, Yumuk
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 19(4)
Although the clinical benefits of trastuzumab are well known, intrinsic or acquired resistance is a commonly encountered clinical condition. A potential resistance mechanism is aberrant downstream signal transmission due to loss of phosphatase and te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8d83cc533d98b2ce6f1052adf8de57cd
https://pubmed.ncbi.nlm.nih.gov/25536593
https://pubmed.ncbi.nlm.nih.gov/25536593
Autor:
Muharrem, Kocar, Emine, Bozkurtlar, Ferhat, Telli, Fulden, Yumuk, Handan, Kaya, Hande, Kocar, Nazim, Serdar Turhal
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 19(1)
Unraveling the mechanisms underlying the resistance to trastuzumab is important for amending the prognosis of patients with human epidermal growth factor receptor 2 (HER2) positive metastatic breast cancer. Experimentally, it has been shown that p95-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c99a289d970a065110345fd2920dde1c
https://pubmed.ncbi.nlm.nih.gov/24659671
https://pubmed.ncbi.nlm.nih.gov/24659671